Skip to main content

PALISADE CAPITAL MANAGEMENT, LP

Position in HRTX — Heron Therapeutics, Inc. /De/

CIK 1009006 FORT LEE, NJ

Position in HRTX

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$4,912,511
-$3,311,435 QoQ
Shares Held
6,140,639
-2.9% QoQ
Ownership
3.23%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 52% Shared 48% None 0%

Common Shares in HRTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

PALISADE CAPITAL MANAGEMENT, LP holds $15,917,613 across 3 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in HRTX

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $4,912,511 6,140,639
2025-12-31 $8,223,946 6,326,113
2025-09-30 $9,232,583 7,327,447
2025-06-30 $10,529,889 5,086,903
2025-03-31 $11,631,248 5,286,931
2024-12-31 $6,007,375 3,926,389
2024-09-30 $7,944,633 3,992,278
2024-06-30 $14,171,948 4,049,128
2024-03-31 $10,338,307 3,732,241
2023-12-31 $6,198,375 3,646,103
2023-09-30 $4,234,279 4,110,951
2023-06-30 $4,806,632 4,143,649
2023-03-31 $5,995,131 3,970,286
2022-12-31 $9,464,737 3,785,895
2022-09-30 $14,300,027 3,388,632
2022-06-30 $8,269,766 2,964,074
2022-03-31 $16,708,732 2,921,107
2021-12-31 $27,701,990 3,034,172
2021-09-30 $26,635,022 2,491,583
2021-06-30 $28,232,913 1,819,131
2021-03-31 $17,243,128 1,063,734
2020-12-31 $18,854,383 890,618
2020-09-30 $12,160,387 820,539
2020-06-30 $9,934,619 675,365
2020-03-31 $7,868,594 670,238